Latest Biosimilars News and Updates : Biosimilars updates, Biosimilars News , Biosimilars around the world

Nishadil

Washington | 20°C (overcast clouds)

Aurobindo’s CuraTeQ Secures Brazil GMP Nod, Paving Way for Biosimilars Expansion

Top story

Aurobindo’s CuraTeQ Secures Brazil GMP Nod, Paving Way for Biosimilars Expansion

In focus

Latest feed

The Humira Enigma: How a Patent Fortress Redefined Pharma Monopolies

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

The Pharmaceutical Frontier: Biosimilars on the Rise

Biocon's Bold Vision: Charting a Course for Global Insulin Leadership

Latest headlines

Roche's Enduring Appeal: Navigating Growth Amidst Valuation Concerns

Roche's Enduring Appeal: Navigating Growth Amidst Valuation Concerns

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Unpacking Pharma's Future: Costs, Generics, and the Tug-of-War for Access

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

Unlocking Affordable Medicine: A Call for Smarter Biosimilar Regulation

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Great Pivot: How Cipla is Betting Big on the Future of Health, Chronic Care, and Yes, Even Obesity

The Great Pivot: How Cipla is Betting Big on the Future of Health, Chronic Care, and Yes, Even Obesity

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs

The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

A New Frontier? Dr. Reddy's, The Weight Loss Revolution, And The Billions At Stake

The Big Play: Dr. Reddy's Bets on a Trio of Launches to Outmaneuver US Market Erosion

The Big Play: Dr. Reddy's Bets on a Trio of Launches to Outmaneuver US Market Erosion

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

Trump's Tariff Threat Looms: How India's Pharma Giants Brace for a 100% Import Duty Shake-up

Trump's Tariff Threat Looms: How India's Pharma Giants Brace for a 100% Import Duty Shake-up

Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers

Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers

Celltrion Fortifies Biologics Dominance with Strategic Eli Lilly Plant Acquisition

Celltrion Fortifies Biologics Dominance with Strategic Eli Lilly Plant Acquisition

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

Alkem Laboratories Unveils 'Perjio': A Landmark Leap in Affordable Breast Cancer Treatment in India

Alkem Laboratories Unveils 'Perjio': A Landmark Leap in Affordable Breast Cancer Treatment in India

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care

The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care

Load more